H.B. Fuller’s 11.57x forward P/E discounts a temporary 4.0x leverage spike while AMS, pricing power, and margin expansion create substantial long-term upside.
Overview
H.B. Fuller is the world’s largest pure-play industrial adhesives company, generating **$3.47 billion of FY2025 revenue** across more than 150 countries, 82 manufacturing sites, and over 30 end markets. Its formulations are mission-critical but typically below 1% of a customer’s bill of materials, creating high switching costs, approximately 87% retention, and resilience against lower-cost competitors. The company is pursuing a portfolio transformation toward specialty, aerospace, electronics, and medical applications through the £715 million AMS acquisition and Project Quantum Leap. Q2 FY2026 revenue rose 5.8% year over year to $950.3 million, organic growth was 2.6%, adjusted gross margin reached 34.2%, adjusted EBITDA increased 9.3% to $181.0 million, and adjusted EPS rose 19% to $1.41. Management raised FY2026 adjusted EBITDA guidance to $650–$675 million and adjusted EPS guidance to $4.60–$4.90. Shares near $57 trade at 11.57x forward P/E versus a 17.6x historical average and 19.0x specialty-chemical peer average. **Near-term leverage and 2027–2028 maturities explain the discount; AMS, cost savings, and margin expansion are the re-rating catalysts.**